Bill Wexler's Dog Pound Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Bill Wexler's Dog Pound

REFR 1.590

-0.6%

10:24 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (501)	3/30/1999 2:39:00 PM
From: mesaone	Read Replies (1) of 10293

Abbott reported today that they signed a deal with Consorta, Inc. This is the sole source contract for intravenous solutions and related products valued at nearly $500 million. biz.yahoo.com it is interesting to note that Hextend, BioTime's first product, a blood plasma expander, will be manufactured and marketed by Abbott.. and today, Abbott has just guaranteed a captive buying audience. I think that perhaps the shorts here should think about revising their estimate on BTIM .. this is great news for BTIM imho.. especially with approval coming very soon.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next